AI
PSTX

Atom Investors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Atom Investors’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82,856
Closed -$795K – 667
2024
Q4 		$795K Buy
+82,856
New +$432K 0.1% 269
2024
Q3 		– Sell
-395,768
Closed -$1.16M – 641
2024
Q2 		$1.16M Sell
395,768
-223,906
-36% -$612K 0.12% 228
2024
Q1 		$1.98M Buy
619,674
+264,058
+74% +$880K 0.25% 133
2023
Q4 		$1.19M Buy
355,616
+199,448
+128% +$514K 0.21% 163
2023
Q3 		$372K Buy
156,168
+106,755
+216% +$224K 0.08% 281
2023
Q2 		$87K Buy
49,413
+18,253
+59% +$46.6K 0.03% 268
2023
Q1 		$96K Sell
31,160
-2,015
-6% -$12.1K 0.05% 226
2022
Q4 		$176K Sell
33,175
-118,945
-78% -$544K 0.09% 184
2022
Q3 		$537K Buy
152,120
+96,293
+172% +$318K 0.19% 147
2022
Q2 		$144K Buy
55,827
+15,007
+37% +$41.7K 0.06% 208
2022
Q1 		$183K Buy
40,820
+15,887
+64% +$71.6K 0.09% 168
2021
Q4 		$170K Buy
+24,933
New +$170K 0.03% 240

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Atom Investors's PSTX Position: Q1 2025 in Review

Atom Investors sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 82,856 shares — an estimated $795K sold.

Atom Investors first reported a position in PSTX in Q4 2021 and held it in 12 quarters. The position peaked at $1.98M in Q1 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Atom Investors reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Atom Investors sold 82,856 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $795K.
  • Atom Investors first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
  • Atom Investors's Poseida Therapeutics, Inc. Common Stock position peaked at $1.98M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Atom Investors's 13F filing for Q1 2025, filed 15 May 2025.